DexCom, Inc. which can be found using ticker (DXCM) now have 19 confirmed analysts covering the stock with the consensus suggesting a rating of ‘strong_buy’. The target price High/Low ranges between 150 and 115 calculating the average target price we see $140.32. Given that the stocks previous close was at $119.29 this would imply there is now a potential upside of 17.6%. The 50 day moving average now sits at $117.81 and the 200 moving average now moves to $107.52. The company has a market cap of 44.85B. The current stock price for Targa Resources Corp. is currently 115.69 USD
The potential market cap would be $52,751,578,919 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 158.48, revenue per share of 7.77 and a 4.7% return on assets.
DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for use by people with diabetes and by healthcare providers. Its Dexcom G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an application on the patient’s mobile device to wirelessly transmit glucose information to the cloud and then to applications on the mobile devices of up to five designated recipients. Its Dexcom Real-Time API enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices. Its other products include Dexcom ONE and Dexcom G7.
